Antigen-presenting cell activation pathway (null)

The antigen-presenting cell activation pathway encompasses the process by which professional antigen-presenting cells (dendritic cells, macrophages, and B cells) process and display antigen peptides via major histocompatibility complexes (MHC) on their surface to T cells, delivering both an antigen-specific signal and a co-stimulatory signal (through molecules such as CD80/CD86 and CD28)[4][1][3][5][7]. This is essential for the activation of naïve T cells, induction of immune effector functions, development of immunological memory, and maintenance of tolerance. The pathway is central to adaptive immunity, bridging innate and adaptive responses, and is targeted indirectly by several immunotherapies and vaccine adjuvants. Dysregulation or manipulation of this pathway impacts immune responses in infection, cancer, and autoimmune conditions[4][7][5][2][1].

Other names

Antigen presentation pathwayAPC activationT cell activation pathway

Modulation of co-stimulatory molecule signaling (e.g., enhancement of CD28–B7 or blockade via CTLA-4) Augmentation of antigen processing and MHC loading Stimulation of APC trafficking and recruitment (adjuvant-mediated)